Mobile Image

The 14-3-3
Molecular Glue
Company

Expanding the druggable
proteome to drug intrinsically
disordered proteins

Ambagon-Home-Option4

Our Science

Our team is developing a new class of medicines that can interact with previously undruggable targets

home-component

Platform & Pipeline

We have built a platform that addresses a wide range of targets previously thought undruggable